Rheumatic Joint Disease clinical trials at UCLA

1 research study open to eligible people

Showing trials for

  • Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry

    open to eligible people ages up to 21 years

    Continuation of the CARRA Registry as described in the protocol will support data collection on patients with pediatric-onset rheumatic diseases. The CARRA Registry will form the basis for future CARRA studies. In particular, this observational registry will be used to answer pressing questions about therapeutics used to treat pediatric rheumatic diseases, including safety questions.

    Los Angeles, California and other locations

Our lead scientists for Rheumatic Joint Disease research studies include .

Last updated: